Question 1

Has Sarah Hwang Hwang received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $1,520 in general payments to Sarah Hwang Hwang across 105 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Sarah Hwang Hwang did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Sarah Hwang Hwang come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Johnson & Johnson(2 entities)	15	$187
AbbVie	16	$180
Pfizer	15	$166
Amgen(2 entities)	11	$157
Novartis	11	$151
Mallinckrodt Enterprises LLC	6	$142
Lilly USA, LLC	4	$72
GSK	4	$67
Sanofi	4	$63
Radius Health, Inc.	3	$62
Bristol Myers Squibb	3	$61
UCB, Inc.	3	$54
Hikma Pharmaceuticals USA	2	$38
E.r. Squibb & Sons, L.L.C.	3	$34
Genentech USA, Inc.	2	$32
Zimmer Biomet	1	$25
Ferring Pharmaceuticals Inc.	1	$19
Sanofi-aventis U.S. LLC	1	$11

Sarah Hwang Hwang

Payments from drug & device makers

Who reported the general payments

How this compares

Other rheumatology in la Palma